Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 12

Results For "collaboration"

1934 News Found

India’s pharma market to hit US$ 130 billion, exports US$ 80 billion by 2030: ASSOCHAM
News | June 12, 2026

India’s pharma market to hit US$ 130 billion, exports US$ 80 billion by 2030: ASSOCHAM

Knowledge paper highlights biosimilars, biologics, AI-driven drug discovery and regulatory excellence as key growth drivers for the next phase of India's pharma expansion


Industry, regulators and quality experts discuss implementation of Indian Pharmacopoeia 2026
Policy | June 12, 2026

Industry, regulators and quality experts discuss implementation of Indian Pharmacopoeia 2026

Indian Pharmacopoeia Commission hosts scientific conclave to brainstorm on strengthening pharmaceutical quality and compliance


Govt approval to KIHT as CRO expands India’s innovation capabilities
Clinical Trials | June 12, 2026

Govt approval to KIHT as CRO expands India’s innovation capabilities

KIHT can now conduct clinical research for drugs and medical devices, strengthening evidence generation and healthcare innovation


Research must translate into real-world solutions: Dr. Jitendra Singh
Policy | June 12, 2026

Research must translate into real-world solutions: Dr. Jitendra Singh

Union Minister inaugurated a DST-funded Central Instrumentation Facility and three new research clusters focused on advanced materials, clean energy, and healthcare at IIT Gandhinagar


IIT Madras releases world’s most detailed 3D Atlas of human brainstem
News | June 12, 2026

IIT Madras releases world’s most detailed 3D Atlas of human brainstem

Developed by the Sudha Gopalakrishnan Brain Centre, the publicly accessible ANCHOR atlas maps over 200 brainstem structures at cellular resolution, offering new possibilities for neuroscience research and clinical applications


Sygnature Discovery partners with DaltonTx to enhance AI-driven drug discovery capabilities
Digitisation | June 11, 2026

Sygnature Discovery partners with DaltonTx to enhance AI-driven drug discovery capabilities

Collaboration aims to accelerate medicinal chemistry decision-making, reduce synthesis burden and strengthen data-secure AI adoption in drug discovery


Glenmark launches Winlevi across key European markets
News | June 11, 2026

Glenmark launches Winlevi across key European markets

First-in-class topical androgen receptor inhibitor marks Glenmark’s first New Chemical Entity (NCE) launch in Europe


Oval Fertility and Merck India partner to advance access to high-quality fertility care
Healthcare | June 10, 2026

Oval Fertility and Merck India partner to advance access to high-quality fertility care

Strategic collaboration aims to strengthen clinical capabilities, enhance patient experience and improve fertility treatment outcomes through scientific expertise, technology and data-driven care


GSK bets big on oncology with $10.6 billion Nuvalent acquisition
News | June 10, 2026

GSK bets big on oncology with $10.6 billion Nuvalent acquisition

Deal brings late-stage lung cancer candidates zidesamtinib and neladalkib into GSK’s portfolio


AmMax Bio licenses Lonza’s ADC tech to advance AML candidate AMB-104
News | June 10, 2026

AmMax Bio licenses Lonza’s ADC tech to advance AML candidate AMB-104

The company gets access to Lonza’s clinically validated SYNtecan linker-payload platform as it prepares an IND filing for its acute myeloid leukemia therapy in 2027